Kristine Peterson's Net Worth
$2.74 Million
Who is Kristine Peterson?
Kristine Peterson has an estimated net worth of $2.74 Million. This is based on reported shares across multiple companies, which include ENANTA PHARMACEUTICALS INC, AMARIN CORP PLC\UK, ImmunoGen, Inc., pSivida Corp., Paratek Pharmaceuticals, Inc., Immunocore Holdings plc, and ArriVent Biopharma, Inc..
SEC CIK
Kristine Peterson's CIK is 0001508596
Past Insider Trading and Trends
2019 was Kristine Peterson's most active year for acquiring shares with 12 total transactions. Kristine Peterson's most active month to acquire stocks was the month of May. 2023 was Kristine Peterson's most active year for disposing of shares, totalling 13 transactions. Kristine Peterson's most active month to dispose stocks was the month of January. 2019 saw Kristine Peterson paying a total of $985,530.00 for 266,753 shares, this is the most they've acquired in one year. In 2019 Kristine Peterson cashed out on 333,667 shares for a total of $3,274,038.45, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ENANTA PHARMACEUTICALS INC (ENTA) Snapshot price: $11.54
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
AMARIN CORP PLC\UK (AMRN) Snapshot price: $0.6094
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
$12.91 | -$2,326,308.45 |
0
|
Scheduled
|
Feb 22
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ImmunoGen, Inc. (IMGN) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
—
|
0
|
$20.24 | -$346,300.00 |
0
|
Scheduled
|
Nov 30
| ||
Form 4
|
—
|
0
|
$15.39 | -$13,800.00 |
0
|
Sep 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
pSivida Corp. (EYPT) Snapshot price: $7.97
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
∞
| 6.67K |
—
|
—
| 6.67K |
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Paratek Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -79.00K |
—
|
—
|
0
|
Sep 21
| |||
Form 4
| +33.90% | 20K |
—
|
—
| 79K |
Feb 8
| |||
Form 4
| +51.28% | 20K |
—
|
—
| 59K |
Feb 16
| |||
Form 4
| +30.00% | 9K |
—
|
—
| 39K |
Feb 18
| |||
Form 4
| +42.86% | 9K |
—
|
—
| 30K |
Feb 19
| |||
Form 4
| +55.56% | 7.5K |
—
|
—
| 21K |
Feb 26
| |||
Form 4
| +125.00% | 7.5K |
—
|
—
| 13.5K |
Feb 14
| |||
Form 4
|
∞
| 6K |
—
|
—
| 6K |
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |